{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:50:02Z","timestamp":1791589802045,"version":"4.3.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The Population-based Sodium\/Potassium Improvement Program is a nonrandomized population-based intervention implemented by the Japanese Society of Hypertension across multiple municipalities and workplaces in Japan. This post hoc regional analysis focused on two municipalities in Hokkaido\u2014namely, Higashikagura, which received standard support, and Mashike, which received intensive support consisting of on-site urinary sodium-to-potassium (Na\/K) ratio measurement, immediate feedback, repeated health guidance, and food-environment improvement. A total of 431 participants who underwent annual health checkups in 2021 and 2022 and had urinary Na\/K ratio data at both time points (standard support group,\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009218; intensive support group,\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009213) were included. One-year changes in the urinary Na\/K ratio, estimated salt and potassium intakes, blood pressure (BP), and other clinical measures were compared between the groups using multivariable linear regression. The proportion of participants achieving urinary Na\/K ratio targets increased in the intensive support group. A significant group-by-time interaction was observed for the &lt;2 threshold (OR 2.62, 95% CI: 1.25\u20135.50), but not for the &lt;4 threshold. After adjustment for covariates, estimated salt intake decreased more in the intensive support group than in the standard support group (adjusted group difference: \u22120.53\u2009g\/day, 95% confidence interval: \u22120.95 to \u22120.12). Changes in the urinary Na\/K ratio, estimated potassium intake, and systolic and diastolic BP did not significantly differ between the groups. Intensive support incorporating urinary Na\/K ratio measurement, immediate feedback, and repeated multidisciplinary guidance may promote salt reduction in local community settings.\n                  <\/jats:p>","DOI":"10.1038\/s41440-026-02846-8","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T10:50:00Z","timestamp":1791543000000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Regional effect of population-based programs promoting salt reduction and potassium intake in Hokkaido: a post hoc analysis of the PoSPIP"],"prefix":"10.1038","author":[{"given":"Hirofumi","family":"Sakuma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsushi","family":"Yoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukari","family":"Takemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Hisamatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rumi","family":"Tsukinoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Hayabuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Okami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Kitaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Hozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayoshi","family":"Ohkubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Hasebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyuki","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,9]]},"reference":[{"key":"2846_CR1","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","volume":"387","author":"D Ettehad","year":"2016","unstructured":"Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387:957\u201367.","journal-title":"Lancet"},{"key":"2846_CR2","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1016\/j.jacc.2022.11.005","volume":"80","author":"M Vaduganathan","year":"2022","unstructured":"Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA. The global burden of cardiovascular diseases and risk: a compass for future health. J Am Coll Cardiol. 2022;80:2361\u201371.","journal-title":"J Am Coll Cardiol"},{"key":"2846_CR3","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s11906-019-0906-2","volume":"21","author":"N Nakagawa","year":"2019","unstructured":"Nakagawa N, Hasebe N. Impact of the 2017 American College of Cardiology\/American Heart Association Blood Pressure Guidelines on the Next Blood Pressure Guidelines in Asia. Curr Hypertens Rep. 2019;21:2.","journal-title":"Curr Hypertens Rep"},{"key":"2846_CR4","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41440-024-01622-w","volume":"47","author":"K Kario","year":"2024","unstructured":"Kario K, Okura A, Hoshide S, Mogi M. The WHO Global report 2023 on hypertension warning the emerging hypertension burden in globe and its treatment strategy. Hypertens Res. 2024;47:1099\u2013102.","journal-title":"Hypertens Res"},{"key":"2846_CR5","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1161\/CIRCULATIONAHA.120.050371","volume":"143","author":"T Filippini","year":"2021","unstructured":"Filippini T, Malavolti M, Whelton PK, Naska A, Orsini N, Vinceti M. Blood pressure effects of sodium reduction: dose\u2013response meta-analysis of experimental studies. Circulation. 2021;143:1542\u201367.","journal-title":"Circulation"},{"key":"2846_CR6","doi-asserted-by":"publisher","first-page":"m315","DOI":"10.1136\/bmj.m315","volume":"368","author":"L Huang","year":"2020","unstructured":"Huang L, Trieu K, Yoshimura S, Neal B, Woodward M, Campbell NRC, et al. Effect of dose and duration of reduction in dietary sodium on blood pressure levels: systematic review and meta-analysis of randomised trials. BMJ. 2020;368:m315.","journal-title":"BMJ"},{"key":"2846_CR7","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1056\/NEJMra2030212","volume":"385","author":"DH Ellison","year":"2021","unstructured":"Ellison DH, Welling P. Insights into salt handling and blood pressure. N Engl J Med. 2021;385:1981\u201393.","journal-title":"N Engl J Med"},{"key":"2846_CR8","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/S0140-6736(18)31376-X","volume":"392","author":"A Mente","year":"2018","unstructured":"Mente A, O\u2019Donnell M, Rangarajan S, McQueen M, Dagenais G, Wielgosz A, et al. Urinary sodium excretion, blood pressure, cardiovascular disease, and mortality: a community-level prospective epidemiological cohort study. Lancet. 2018;392:496\u2013506.","journal-title":"Lancet"},{"key":"2846_CR9","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"G Mancia","year":"2023","unstructured":"Mancia G, Kreutz R, Brunstrom M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41:1874\u20132071.","journal-title":"J Hypertens"},{"key":"2846_CR10","unstructured":"Organization WH. Guideline: sodium intake for adults and children. World Health Organization: Geneva. 2012."},{"key":"2846_CR11","first-page":"e13","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71:e13\u2013e115.","journal-title":"Hypertension"},{"key":"2846_CR12","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/s41440-019-0284-9","volume":"42","author":"S Umemura","year":"2019","unstructured":"Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese Society of Hypertension Guidelines for the management of hypertension (JSH 2019). Hypertens Res. 2019;42:1235\u2013481.","journal-title":"Hypertens Res"},{"key":"2846_CR13","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/s41440-021-00843-7","volume":"45","author":"M Kogure","year":"2022","unstructured":"Kogure M, Nakamura T, Tsuchiya N, Hirata T, Nochioka K, Narita A, et al. Consideration of the reference value and number of measurements of the urinary sodium-to-potassium ratio based on the prevalence of untreated home hypertension: TMM Cohort Study. Hypertens Res. 2022;45:866\u201375.","journal-title":"Hypertens Res"},{"key":"2846_CR14","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41440-018-0152-z","volume":"42","author":"T Thi Minh Nguyen","year":"2019","unstructured":"Thi Minh Nguyen T, Miura K, Tanaka-Mizuno S, Tanaka T, Nakamura Y, Fujiyoshi A, et al. Association of blood pressure with estimates of 24-h urinary sodium and potassium excretion from repeated single-spot urine samples. Hypertens Res. 2019;42:411\u20138.","journal-title":"Hypertens Res"},{"key":"2846_CR15","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1038\/s41440-019-0276-9","volume":"42","author":"Y Higo","year":"2019","unstructured":"Higo Y, Nagashima S, Tabara Y, Setoh K, Kawaguchi T, Takahashi Y, et al. Association of the spot urine sodium-to-potassium ratio with blood pressure is independent of urinary Na and K levels: The Nagahama study. Hypertens Res. 2019;42:1624\u201330.","journal-title":"Hypertens Res"},{"key":"2846_CR16","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1161\/HYPERTENSIONAHA.117.09928","volume":"71","author":"J Stamler","year":"2018","unstructured":"Stamler J, Chan Q, Daviglus ML, Dyer AR, Van Horn L, Garside DB, et al. Relation of dietary sodium (Salt) to blood pressure and its possible modulation by other dietary factors: The INTERMAP Study. Hypertension. 2018;71:631\u20137.","journal-title":"Hypertension"},{"key":"2846_CR17","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41440-020-00536-7","volume":"44","author":"M Kogure","year":"2021","unstructured":"Kogure M, Nakaya N, Hirata T, Tsuchiya N, Nakamura T, Narita A, et al. Sodium\/potassium ratio change was associated with blood pressure change: possibility of population approach for sodium\/potassium ratio reduction in health checkup. Hypertens Res. 2021;44:225\u201331.","journal-title":"Hypertens Res"},{"key":"2846_CR18","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1056\/NEJMoa2109794","volume":"386","author":"Y Ma","year":"2022","unstructured":"Ma Y, He FJ, Sun Q, Yuan C, Kieneker LM, Curhan GC, et al. 24-hour urinary sodium and potassium excretion and cardiovascular risk. N Engl J Med. 2022;386:252\u201363.","journal-title":"N Engl J Med"},{"key":"2846_CR19","doi-asserted-by":"publisher","first-page":"3288","DOI":"10.1038\/s41440-024-01861-x","volume":"47","author":"T Hisamatsu","year":"2024","unstructured":"Hisamatsu T, Kogure M, Tabara Y, Hozawa A, Sakima A, Tsuchihashi T, et al. Practical use and target value of urine sodium-to-potassium ratio in assessment of hypertension risk for Japanese: consensus statement by the Japanese Society of Hypertension Working Group on urine sodium-to-potassium ratio. Hypertens Res. 2024;47:3288\u2013302.","journal-title":"Hypertens Res"},{"key":"2846_CR20","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1038\/s41440-026-02662-0","volume":"49","author":"T Hisamatsu","year":"2026","unstructured":"Hisamatsu T, Kinuta M, Ohkubo T, Tsuchihashi T, Yoshita K, Takemi Y, et al. Effect of population-approach programs promoting salt reduction and potassium intake in Japan: the population-based sodium\/potassium improvement program (PoSPIP). Hypertens Res. 2026;49:1992\u20132003.","journal-title":"Hypertens Res"},{"key":"2846_CR21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/sj.jhh.1001307","volume":"16","author":"T Tanaka","year":"2002","unstructured":"Tanaka T, Okamura T, Miura K, Kadowaki T, Ueshima H, Nakagawa H, et al. A simple method to estimate populational 24-h urinary sodium and potassium excretion using a casual urine specimen. J Hum Hypertens. 2002;16:97\u2013103.","journal-title":"J Hum Hypertens"},{"key":"2846_CR22","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/hr.2016.79","volume":"39","author":"K Yasutake","year":"2016","unstructured":"Yasutake K, Miyoshi E, Kajiyama T, Umeki Y, Misumi Y, Horita N, et al. Comparison of a salt check sheet with 24-h urinary salt excretion measurement in local residents. Hypertens Res. 2016;39:879\u201385.","journal-title":"Hypertens Res"},{"key":"2846_CR23","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/s41440-024-01644-4","volume":"47","author":"K Node","year":"2024","unstructured":"Node K, Tanaka A. Our mission in the Japanese Society of Hypertension (JSH) Future Plan: a baton-connection from JSH Osaka 2023 to Fukuoka 2024. Hypertens Res. 2024;47:1097\u20138.","journal-title":"Hypertens Res"},{"key":"2846_CR24","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1056\/NEJMoa1304127","volume":"371","author":"D Mozaffarian","year":"2014","unstructured":"Mozaffarian D, Fahimi S, Singh GM, Micha R, Khatibzadeh S, Engell RE, et al. Global sodium consumption and death from cardiovascular causes. N Engl J Med. 2014;371:624\u201334.","journal-title":"N Engl J Med"},{"key":"2846_CR25","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1136\/bmjnph-2021-000408","volume":"5","author":"M Tan","year":"2022","unstructured":"Tan M, He F, Morris JK, MacGregor G. Reducing daily salt intake in China by 1 g could prevent almost 9 million cardiovascular events by 2030: a modelling study. BMJ Nutr Prev Health. 2022;5:164\u201370.","journal-title":"BMJ Nutr Prev Health"},{"key":"2846_CR26","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/jhh.2015.84","volume":"30","author":"T Iwahori","year":"2016","unstructured":"Iwahori T, Ueshima H, Torii S, Saito Y, Fujiyoshi A, Ohkubo T, et al. Four to seven random casual urine specimens are sufficient to estimate 24-h urinary sodium\/potassium ratio in individuals with high blood pressure. J Hum Hypertens. 2016;30:328\u201334.","journal-title":"J Hum Hypertens"},{"key":"2846_CR27","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41440-019-0335-2","volume":"43","author":"M Kogure","year":"2020","unstructured":"Kogure M, Hirata T, Nakaya N, Tsuchiya N, Nakamura T, Narita A, et al. Multiple measurements of the urinary sodium-to-potassium ratio strongly related home hypertension: TMM Cohort Study. Hypertens Res. 2020;43:62\u201371.","journal-title":"Hypertens Res"},{"key":"2846_CR28","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/hr.2014.76","volume":"37","author":"T Iwahori","year":"2014","unstructured":"Iwahori T, Ueshima H, Miyagawa N, Ohgami N, Yamashita H, Ohkubo T, et al. Six random specimens of daytime casual urine on different days are sufficient to estimate daily sodium\/potassium ratio in comparison to 7-day 24-h urine collections. Hypertens Res. 2014;37:765\u201371.","journal-title":"Hypertens Res"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02846-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02846-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02846-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:01:57Z","timestamp":1791586917000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02846-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,9]]},"references-count":28,"alternative-id":["2846"],"URL":"https:\/\/doi.org\/10.1038\/s41440-026-02846-8","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,9]]},"assertion":[{"value":"12 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Our study was approved by the institutional review board committee of the Japanese Society of Hypertension (approval no. 2023-001) and the Ethics Committee of Asahikawa Medical University (approval no. 24129). The institutional review board waived the requirement for informed consent because the study used deidentified data and involved the secondary use of existing data.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}